Fibrinogen and homocysteine levels in coronary artery disease

S Gheye1, A V Lakshmi, T P Krishna

  • 1National Institute of Nutrition, Hyderabad.

Indian Heart Journal
|March 18, 2000
PubMed

Insights

In the Indian population, elevated plasma fibrinogen and abdominal obesity are significantly linked to coronary artery disease. These factors, along with high cholesterol, contribute to the disease beyond traditional risks.

Area of Science:

  • Cardiology
  • Biochemistry
  • Public Health

Background:

  • Traditional coronary artery disease (CAD) risk factors inadequately explain disease burden in India.
  • Emerging risk factors, including plasma fibrinogen and homocysteine, are recognized for their role in CAD.
  • Investigating novel risk factors is crucial for understanding CAD in diverse populations.

Purpose of the Study:

  • To assess the association of plasma fibrinogen, homocysteine, lipid profiles, and anthropometric parameters with angiographically confirmed CAD.
  • To explore relationships between biochemical and anthropometric markers in CAD patients.
  • To identify specific risk factors prevalent in the Indian population.

Main Methods:

  • A case-control study involving 58 male CAD patients (35-60 years) and 58 matched controls.
  • Measurement of plasma fibrinogen, homocysteine, lipid profiles, and anthropometric indices (waist-to-hip ratio, waist-to-thigh ratio).
  • Statistical comparison of parameters between CAD cases and control groups.

Main Results:

  • CAD cases exhibited significantly higher waist-to-hip ratio, waist-to-thigh ratio, plasma fibrinogen, and total cholesterol.
  • No significant difference in mean plasma total homocysteine levels was observed between cases and controls.
  • Elevated plasma fibrinogen and abdominal obesity demonstrated a significant association with CAD.

Conclusions:

  • Plasma fibrinogen and abdominal obesity are significant risk factors for coronary artery disease in the Indian population.
  • These factors contribute to CAD independently of conventional risk factors.
  • Further research into these markers can inform targeted prevention strategies for CAD in India.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...